Dobbs, K, Tabellini, G, Calzoni, E, Patrizi, O, Martinez, P, Giliani, SC, Moratto, D, Al-Herz, W, Cancrini, C, Cowan, MJ, Bleesing, J, Booth, C, Buchbinder, DK, Burns, SO, Chatila, TA, Chou, J, Daza-Cajigal, V, Ott de Bruin, LM, de la Morena, MT, Di Matteo, G, Finocchi, A, Geha, RS, Goyal, RK, Hayward, A, Holland, SM, Huang, C-H, Kanariou, MG, King, A, Kaplan, B, Kleva, A, Kuijpers, TW, Lee, BW, Lougaris, V, Massaad, M, Meyts, I, Morsheimer, M, Neven, B, Pai, S-Y, Parvaneh, N, Plebani, A, Prockop, S, Reisli, I, Soh, JY, Somech, R, Torgerson, TR, Kim, Y-J, Walter, JE, Gennery, AR, Keles, S, Manis, JP, Marcenaro, E, Moretta, A, Parolini, S & Notarangelo, LD 2017, '
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content',
Frontiers in Immunology [E], vol. 8, 1244.
https://doi.org/10.3389/fimmu.2017.01244